<DOC>
	<DOC>NCT00212381</DOC>
	<brief_summary>To determine if the use of oral Diindolylmethante (DIM), a marketed cruciferous vegetable based dietary supplement (Bioresponse-DIM), is associated with the regression of cervical dysplasia in otherwise healthy women.</brief_summary>
	<brief_title>Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia</brief_title>
	<detailed_description>To determine if the use of oral Diindolylmethane (DIM), a marketed cruciferous vegetable based dietary supplement (BioResponse-DIMÂ®), is associated with the regression of cervical dysplasia in otherwise healthy women. Additionally, the study aims to see how the use of the BioResponse-DIM supplement correlates with cervical HPV colonization, and to asses the tolerability of daily DIM supplementation</detailed_description>
	<mesh_term>Cervical Intraepithelial Neoplasia</mesh_term>
	<mesh_term>Uterine Cervical Dysplasia</mesh_term>
	<criteria>Non pregnant women greater than or equal to 18 years of age able to consent CIN II or III confirmed by histology Karnofsky performance status &gt;= 80 No prior treatment for dysplasia in the past 4 months Incompletely visible lesion Diethylstilbestrol (DES) exposure HIV seropositive</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>cervical dysplasia, diindolylmethane, pap smear</keyword>
</DOC>